Additionally, refractory hypoglycemia, known as Doege-Potter syndrome, occurs in 1 %–2 % of cases, often due to the secretion of insulin-like growth factor II, which is more common in larger or malignant tumors [[12], [13], [14]]. The gene discussed is IGF2; the disease is cancer.